Trial Details
COMPLETEDBasic Information
| Clinical ID | c517 |
|---|---|
| Identifier | NCT02986724 |
| Trial Title | A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Colitis, Ulcerative|Inflammatory Bowel Diseases |
| Interventions | - |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Innsbruck |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2017-01-04 |
|---|---|
| Primary Completion Date | 2020-08-31 |
| Completion Date | 2020-08-31 |